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Metabolic homeostasis is achieved by complex
molecular and cellular networks that differ signifi-
cantly among individuals and are difficult to model
with genetically engineered lines of mice optimized
to study single gene function. Here, we systemati-
cally acquired metabolic phenotypes by using the
EUMODIC EMPReSS protocols across a large panel
of isogenic but diverse strains of mice (BXD type) to
study the genetic control of metabolism. We gener-
ated and analyzed 140 classical phenotypes and
deposited these in an open-access web service for
systems genetics (www.genenetwork.org). Herita-
bility, influence of sex, and genetic modifiers of traits
were examined singly and jointly by using quantita-
tive-trait locus (QTL) and expression QTL-mapping
methods. Traits and networks were linked to loci en-
compassing both known variants and novel candi-
date genes, including alkaline phosphatase (ALPL),
here linked to hypophosphatasia. The assembled
and curated phenotypes provide key resources and
exemplars that can be used to dissect complex
metabolic traits and disorders.
INTRODUCTION
Energy homeostasis is the result of a tight balance between
energy intake and expenditure. Metabolic disorders, such as
obesity and type 2 diabetes, often result when this equilibrium
is disturbed by complex interactions between genetic and envi-
ronmental factors (Auwerx, 2006). Predisposition to complex
diseases such as the metabolic syndrome is inherited in a non-CMendelian fashion, emphasizing genetic heterogeneity and
complex gene-by-environment interactions (GXE) in pathogen-
esis. Genetically engineered mouse models are not ideal for
dissecting polygenic networks or GXE interactions precisely
because they have been optimized to study actions of single
genes on single genetic backgrounds (Auwerx et al., 2004). In
contrast, studies in humans have identified risk factors for devel-
oping metabolic diseases with both environmental (e.g., lack of
exercise) and genetic causes (e.g., mutations in the FTO locus
[Dina et al., 2007]), but these studies typically fall short of defining
GXE due to an inability to control environmental influences,
cohort and admixture effects, difficulty in obtaining certain types
of physiological and molecular data, and the inability to sample
many individuals with identical genomes under different con-
ditions. Effective population-based experimental methods to
dissect intricate GXEs are needed to model complex genetically
admixed human populations.
Over the past decades, study designs have been optimized to
analyze genetic factors in large populations of naturally divergent
strains, chiefly in Mus musculus, Saccharomyces cerevisiae
(Brem et al., 2002; Ehrenreich et al., 2010), Drosophila (King
et al., 2012), and more recently, Caenorhabditis elegans (Ander-
sen et al., 2012). Murine genetic reference populations (GRPs)
are among the best-established mammalian models with which
to studyGXE. TheseGRPs are typically sets of inbred strains that
have been assembled to incorporate carefully titered levels of
genetic complexity that model aspects of human populations.
The recombinant inbred (RI) strain families are a type of GRP
that enable tight experimental control, where each genotype
is represented by an entire isogenic line, thereby enabling exten-
sive replication studies (Singer et al., 2004; Williams et al., 2001).
The BXD family, currently the largest and best characterized
mouse GRP, is composed of 160 lines that descend from
crosses between C57BL/6J and DBA/2J, hereafter referred to
as B and D, respectively (Peirce et al., 2004). GRPs such asell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc. 1287
the BXDs have been bred for quantitative trait loci (QTL) anal-
yses, a suite of statistical genetic techniques that define regions
of the genome (intervals or loci) and their modulating effects on
phenotype. Another major advantage of GRPs is that high-
density genotype data are publicly available. These genotypes
can be combined with full-sequence data of the parental strains
to simplify QTL mapping and identify causal sequence variants
(Mozhui et al., 2008; Wang et al., 2010). Furthermore, owing to
the relatively fixed genotypes of GRPs, massive databases of
phenotypes and expression data can be assembled and shared
across time, allowing for rapidmultiscalar analyses. Over the last
two decades, the BXD family has been exploited mainly to study
the genetics of immune function and infectious disease (By-
strykh et al., 2005; Miyairi et al., 2007) and in behavioral and
neuropharmacological research (Chesler et al., 2005; Gaglani
et al., 2009; Laughlin et al., 2011; Philip et al., 2010). However,
few metabolic phenotypes have been previously generated.
In the present metabolic survey, we systematically generated
quantitative data for 140 standardized phenotypes, including
glucose response, body weight change, physical activity, and
oxygen consumption across a large subset of the BXD family
by using adult males and females. All data are publicly available
as a resource to the scientific community and complement
massive expression data for key cells, tissues, and organs that
we and others have deposited in the GeneNetwork database
(www.genenetwork.org; see BXD phenotypes found under
search term ‘‘LISP1’’). These essential baseline clinical pheno-
types are widely variable, often highly heritable, and in many
cases can be linked to genetic loci encompassing known and
novel candidate genes. Heritability and sex effects were highly
variable among traits. Variation in one key trait, alkaline phos-
phatase, was linked to hypophosphatasia in lines containing
the C57BL/6 allelic variant. Downstream of this hypophosphata-
sia, differences in bone structure were noted, as well as a sig-
nificant increase in pyridoxal-phosphate (PLP) levels and a
corresponding decrease in pyrixodal levels. This study validates
the use of GRPs as a powerful resource to study metabolic
homeostasis and identifies new candidate genes for disease.
RESULTS
Optimization Study Design for Genetics of Metabolism
Mendelian traits such as coat color can be accurately measured
with a sample size of one per genotype. In contrast, complex
metabolic traits with lower heritability benefit greatly from larger
sample sizes per genotype. One of the advantages of GRPs over
noninbred yet genetically diverse strain populations (such as an
F2 intercross) is that the heritability of a trait can be accurately
measured and effectively boosted by repeatedly resampling
cohorts of isogenic individuals of the same genotype and sex
(Figure 1A). The observed variability within isogenic strains is
thus primarily environmental, whereas differences among strains
are largely genetic. A first step in experimental designs using
GRPs is to estimate heritability and the sample size required to
accurately measure a phenotype in a specific environment.
Such calculations provide both a justifiable number of replicates
per genotype and the total numbers of genotypes needed to
reliably discriminate gene loci by using QTL-mapping methods.1288 Cell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc.When traits have high heritability, increasing the number of
genotypes (i.e., strains) greatly improves the power and preci-
sion with which QTLs can be mapped, whereas increasing the
number of cases per genotype has almost no impact (Figure 1B,
top). In the case of a Mendelian trait such as coat color, muta-
tions in the brown (Tyrp1) and dilute (Myo5a) genes explain
nearly all variation in pigmentation in the BXD family and map
with peak LOD scores above 25 at these genes (Geisert et al.,
2009). In contrast, complex diseases, including virtually all meta-
bolic disorders, are polygenic, more dependent on environmen-
tal influences, and typically have a nearly normal distribution
across genotypes. Power analysis shows that a study using 20
BXD strains with four animals per genotype will often detect
loci that explain 50% or more of the genetic variance of a moder-
ately heritable trait, whereas a study using 40 strains will typi-
cally detect loci responsible for30%of the variance (Figure 1B,
bottom).
We phenotyped a set of 43 strains—24 strains with male and
female animals, 18 strains only with males, and 1 strain only
with females (Figure 1C). Phenotyping was initiated at 13 weeks
of age, and all cases underwent seven testing categories
(Figures 1C and 1D). Mapping power was estimated as a func-
tion of heritability and sample size. We defined heritability as
the ratio of the within-strain variance to total sample variance
(Figure 1D). Most parameters have moderate to high heritability
(h2), averaging 0.67. The more heritable a trait, the higher the
likelihood it will map to significant QTLs (Lynch and Walsh,
1998). Under the tightly controlled environmental conditions in
our vivarium, both glucose tolerance and blood pressure had
h2 0.7. Consistent with these moderately high values, each
of these traits was associated with at least one significant
locus. In the case of blood pressure, we have defined a strong
candidate gene—UBP1—by using a human genome-wide
association study (GWAS) as a cross validation cohort (Koutni-
kova et al., 2009).
The BXD GRP allows complementary forward and reverse
genetic methods to analyzemetabolic traits (Figure 1E). Conven-
tional forward-mapping methods start with heritable differences
in phenotype and define loci and sequence variants (Figures 1E
and S1A available online). Reverse genetics starts from defined
candidate genes and identifies downstream phenotypic effects
(Figures 1E and S1B) (Thomas et al., 2009; Yamamoto et al.,
2011). Because full-sequence data are available for both
parental strains of the BXD family, reverse methods can now
be applied genome-wide by using a standard mapping popu-
lation. In this resource, we demonstrate both approaches to
the data.
The BXD Family Has Wide Variation in Metabolic Traits
Metabolic traits vary to a remarkable degree among the BXD
strains, with every trait showing significant variation (Figure 2A).
The least variable trait, basal body temperature, varied signifi-
cantly (from 35.8 ± 0.3C in BXD34 to 38.9 ± 0.2C in BXD95)
despite an overall variation of less than 1.1-fold. The most vari-
able trait, alkaline phosphatase (ALPL) protein activity level,
varied 6.5-fold between BXD31 (44 ± 11 U/l) and BXD90 (287 ±
18 U/l). For the majority of traits, the distribution of phenotypes
is continuous and approximately normal in both sexes.
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Figure 1. Study Design for Identifying Genetic Loci that Control Metabolic Traits
(A) The BXD lines were created by crossing B and D parents. The resulting heterozygous F1 mice were again crossed to generate genetically diverse but
nonreproducible F2 animals. These F2 progeny were iteratively inbred until generation F20+, at which point the genome was 99.5+% isogenic and the strains are
considered fully inbred and together constitute a GRP. The 160 BXD strains are numbered 1–183.
(B) Top: power depends mainly on strain number instead on number of mice/strain. Calculations are for a trait variance fixed at 33%. Bottom: the power to detect
a given fraction of variance with a single QTL. Power was calculated with cohort size fixed at four. Both calculations were done for a trait with heritability of 0.67.
(C) All animals underwent the same phenotyping programs as specified in the result section. The age corresponds to the timing of the phenotype experiment.
BXD60 was only phenotyped in females—all other female strains overlapped with male strains.
(D) Heritability of select traits from each phenotyping group. Traits discussed in-depth in this resource paper are indicated in black. Traits are grouped according
to phenotyping test. ‘‘Body Composition’’ represents echocardiography phenotypes, bone size, bone density, and body weight.
(E) The analysis flow-chart. The cause-to-consequence effect reads from top to bottom. A SNP induces a change in the expression or function of a candidate
gene, which has an impact on a given downstream effect or phenotype.
Related to Figure S1.As expected, sex differences are a significant source of vari-
ance (Champy et al., 2004), with the more variable traits more
likely to exhibit significant sexual dimorphism (Figure 2B). Traits
can be divided into four categories in terms of the significance of
variation and correlations between sexes. Nearly 60% of traits
had no significant sex differences. These traits fall into two cate-
gories: those without tight male-female correlation (e.g., short-
ening fraction in Figure 2C) and those with it (e.g., red blood
cell volume in Figure 2D). The first category, with no significant
sex differences and without strong correlation between males
and females, indicates phenotypes where variation cannot beCreliably attributed to genetic factors (i.e., variation is due to envi-
ronmental or technical influence) or that there is a strong sex-by-
strain interaction effect. In the case of the shortening fraction, we
suspect the former factor as the cause of the low heritability (h2 =
0.5) of this trait (Figure 2C). In contrast, the traits with strong
correlations between sexes indicate that the genetic variability
is not affected greatly by the environment, and thus the slope
of the correlation is close to 1 (Figure 2D).
The remaining 40% of traits exhibit significant differences
between males and females, and again with or without strong
male-female correlation. The most striking example is bodyell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc. 1289
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Figure 2. Strain and Sex Influences Differ Widely between Parameters
(A) Metabolic phenotype variation for all cohorts.
(B) Traits with higher variation were more likely to have significant differences between males and females; 41% of traits are significantly different (traits on the
x axis lower than rank 22).
(C) Example of a sex-independent trait that is mostly determined by environment: the ventricular shortening fraction.
(D) Example of a sex-independent trait that is mostly determined by genetics: the mean cell volume of red blood cells.
(E) Example of a sex-influenced trait that is explained by a mix of genetic and environmental factors: body weight at 18 weeks.
Bar graphs and X-Y plots are expressed as mean + SEM.weight, with a dramatic difference between males and females,
but without consistency across strains: e.g., BXD75 males are
the leanest, whereas the BXD75 females are in the middle range
of body weights (Figure 2E). Lastly, a few traits had both signifi-
cant sex-associated differences and strong genetic correla-
tion—one of them being discussed in Figure 4.
QTLs Link Phenotypes to Causal Loci
The data sets generated consist of both general blood parame-
ters, such as hematocrit and iron levels, and physical pheno-
types, such as heart rate and oxygen consumption. Suggestive
or significant QTLs were detected for nearly 40% of all pheno-
types (Table S1). Traits with the highest heritability and the
most significant QTLs usually mapped to a single locus. These
traits are exemplified by the tissue-nonspecific (liver/bone/
kidney) ALPL (also commonly known as TNSALP) protein
activity, a trait for which 58% of the variance is explained by
the single peak QTL (Figure 3A). Many other traits, including
most classical phenotypes, map to several suggestive or signif-
icant loci. In these cases, oligogenic or polygenic networks of
unlinked loci influence trait variance. One good example is basal
oxygen consumption (VO2), a trait for which three loci indepen-
dently contribute to phenotypic variation—21% for the most
significant locus on Chr1, 18% for the locus on Chr4, and 8%
for the locus on Chr11 (Figure 3B).
Genes located within QTLs were examined for known links to
function by using PubMed andGeneRIF (Mitchell et al., 2003). All
but one of the top ten QTLs contained at least one strong posi-1290 Cell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc.tional and functional candidate (Figure 3C). In some cases, the
positional candidate is well established as the causative gene
behind the QTL. This is best illustrated by hematocrit levels,
which map to a locus containing the hemoglobin gene (Popp,
1962). In other cases, the candidates are linked more tentatively.
For example, the QTL for bone surface area contains the steroid
5 alpha-reductase 1 (Srd5a1) gene, which has been linked to
bone mass in a recent study on Srd5a1 knockout mice (Windahl
et al., 2011).
Genetic Polymorphisms Underlying Variation in ALPL
Levels Contribute to Changes in Bone and Vitamin B6
Homeostasis
SerumALPL levels are strongly variable among BXD strains, with
females having significantly higher expression (but less variation)
thanmales (Figures 4A and S2A). Expression of AlplmRNA in the
liver is also highly variable but does not differ by sex (Figures 4A
and S2B) (Gatti et al., 2007). Interestingly, both Alpl mRNA and
ALPL protein activity are highly correlated by strain, regardless
of the sex of the animal (Figure 4B), suggesting strong genetic
modulation and a sex effect shared by all strains. Data for
ALPL activity in males and females map to a common QTL: an
11 Mb region of Chr4 (Figure 4C) that has already been reported
in an F2 cross between C57BL/6 and DBA/2 mice (Foreman
et al., 2005). AlplmRNA also map to the same region (Figure 4C).
This QTL harbors 100 genes, including the Alpl gene itself.
We hypothesized that differences in ALPL activity are primarily
and perhaps almost exclusively caused by one or more allelic
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Figure 3. Analysis of Peak Trait QTLs
(A) The genetic variation attributable to a QTL is calculated by the correlation between the trait values (here, ALPL levels) and the genotype at the peak location.
ALPL has only one QTL, which explains 58% of the genetic variation.
(B) The genetic variation attributable to each of the three QTLs mapped to oxygen consumption. Each QTL has a much smaller effect, but together account for
a large amount of variation. Generalized linear modeling or ANOVA (used here) is necessary to calculate the variation independently attributable to each QTL for
traits which map to multiple QTLs.
(C) The LOD score, corrected p value, andQTL peak location are given alongwith the trait for the top 10 distinct phenotypes. Of note, this is not all of the significant
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54 traits with suggestive or significant peak QTLs is available in Table S1.differences in the cognate Alpl gene, i.e that this is a so-called
cis-regulated expression QTL (cis eQTL). Rapid identification of
all sequence variants in the region was performed by using
a mouse SNP database (www.genenetwork.org). Of 11 exonic
SNPs that differentiate B and D haplotypes of Alpl, nine cause
synonymous mutations and two cause missense mutations in
exon 9, resulting in amino acid changes of R318Q and L324P
(Figure S2C). We modeled the impact of these mutations on
ALPL protein structure by using Phyre2 (www.sbg.bio.ic.ac.uk/
phyre2/) (Figure 4D). Although these mutations are not located
in the active site of ALPL (around S110) (UniProt Consortium,
2012), they are predicted to change the b sheet/a-helix structure
(R318Q and L324P are in green in Figure 4D, showing the
described excerpt of ALPL ± 21 amino acids). Remarkably,
mouse and human ALPL protein sequences share 93%/97%
identity/homology. In particular, the region harboring the two
SNPs is highly conserved in vertebrates—notably proline 324
is invariant in other vertebrates, except in C57BL/6 where it
has mutated into leucine (Figure 4E, same excerpt as in 4D).
Moreover, the high degree of conservation of the ALPL protein
is also revealed by phylogenetic tree analysis—human ALPL
has 77%/87% sequence identity/homology with zebrafish
ALPL, 44%/61% with D. melanogaster, and 32%/45% withCE. coli (Figure 4E). ALPL orthologs separate into three clusters:
vertebrates, insects, and bacteria (Figure 4F). Given this high
genetic conservation, it is likely ALPL has functions in verte-
brates that are wholly unrelated to bone structure.
In humans, mutations in the ALPL gene can cause varying
degrees of hypophosphatasia (Mornet, 2008), a disorder nearly
always associated with the accumulation of phosphoethanol-
amine (PEA) in the urine, extracellular pyridoxal-50-phosphate
(PLP) in the blood, and extracellular inorganic pyrophosphate
(PPi) in urine and blood. Downstream of these biomarkers are
many pathways involved in bone remodeling (Whyte, 2000),
amino acid metabolism, and neurotransmitter regulation (Leh-
ninger et al., 2008). Therefore, we examined patterns of segrega-
tion of phenotypes among BXDs by testing several strains with
either the B allele (C57BL/6, BXD48, BXD65, BXD68, BXD75,
and BXD103) or the D allele of Alpl (DBA/2, BXD89, BXD90,
and BXD95). We first reconfirmed that ALPL enzymatic activity
was different among strains carrying the alleles (Figure 5A).
As predicted, extracellular PLP levels were strongly negatively
correlated with ALPL in both sexes, supporting the hypothesis
that the BXDs are a good model for hypophosphatasia (Fig-
ure 5B). Furthermore, ALPL levels did not correlate with levels
of calcium or phosphate (Pi) (Figure S3A), consistent with studiesell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc. 1291
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Figure 4. Reducing the ALPL QTL to Its Causative Mutation between DBA and C57 Alleles
(A) Expression variation of serum ALPL activity and mRNA levels from liver transcriptome data. Strains with the D allele (red) have significantly more ALPL protein
and Alpl mRNA than strains with the B allele (white) for all comparisons (p < 0.005). Males have significantly less ALPL protein than females, but there is no
difference in mRNA levels.
(B) Correlation between male and female Alpl mRNA and ALPL protein levels demonstrate high trait heritability (Figure 1D).
(C) QTL map for liver AlplmRNA and blood ALPL levels in males and females. All four QTLs (male and female traits are mapped separately) mapped to the same
location and crossed the significance threshold of p < 0.05, indicated by the red horizontal line. The Alpl gene is located below the rectangular peak at right.
(D) 3D model of ALPL from Phyre2, based on the crystal structure of the placental form of ALP (ALPP). Enlarged on the right are the structure of the amino acids
flanking and including the two missense mutations (noted in green).
(E) Forty-four amino acid excerpt of sequence comparison of orthologs of ALPL, the amino acid sequence of the region modeled in (D) is shown here. The full
protein sequence is highly conserved in mammals (>90% homology) and moderately from mammals to bacteria (>30% homology).
(F) Phylogenetic tree ofAlpl. The gene has orthologs in all known species, notably including invertebrates. Bar graphs and X-Y plots are expressed asmean+SEM.
Related to Figure S2.in humans differentiating hypophosphatasia from rickets and
osteomalacia (Whyte, 2000). Femur bone structure evaluated
via micro computed tomography (microCT) indicated decreased
bone area and volume in females with the B allele of Alpl (Fig-
ure 5C), with no difference in overall animal weight between
cohorts (p = 0.76). The same tendency was also noted for males
(Figure S3B). Together these data suggest that the BXD strains
are a useful model for hypophosphatasia.
It is very plausible that the differential regulation of PLP (Fig-
ure 5B) by ALPL drives further phenotypic changes (Figure 5D).
PLP acts as a cofactor in many important biochemical reactions:
principally, it is a required prosthetic group for all aminotransfer-
ases, suggesting a critical role in amino acid metabolism (Leh-
ninger et al., 2008), and it is also an essential coenzyme for
biosynthesis of heme (Astner et al., 2005). Confirmation of this
link between ALPL over PLP to amino acid and hematological
parameters warrants future work.
Wide Variation in Glucose Response Identifies Genetic
Factors of Diabetes
Analysis of complex metabolic phenotypes also yielded QTLs
with promising candidates. One such phenotype is glucose
response during intraperitoneal glucose tolerance test (IPGTT),1292 Cell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc.which records glycaemia levels before and 15, 30, 60 and
120min after glucose injection and the overall glucose excursion
curve (AUC). The AUC is significantly higher in males (Figure 6A)
but correlates between the sexes (Figure 6B and Table S2A). The
AUC is also linked to physical parameters such as body weight
and composition in males, but surprisingly, not in females (Fig-
ure 6B and Tables S2B and S2C), perhaps partly explained by
the fact that fewer female strains were studied. These results
show that variation in glucose response is significantly deter-
mined by genetics and partly sex independent. Consistent with
these observations, mapping QTLs for glucose levels during
IPGTT revealed both common and distinct loci in both sexes
(Figure S4).
All genes under the four significant or suggestive QTLs for
female glucose response on Chrs1, 2, 7 and 9 (Figure 6C) were
investigated. The locus on Chr1 was associated with late glu-
cose response, with glycaemia at 120 min giving the highest
LOD score (Figure 6C). Within this locus, two genes are associ-
ated with type 2 diabetes susceptibility in humans: cytosolic
phospholipase A2 group IV gene (Pla2g4a) and prostaglandin-
endoperoxide synthase 2 (Ptgs2, previously known as Cox2),
both involved in prostaglandin metabolism (Konheim and Wolf-
ord, 2003; Wolford et al., 2003). A second QTL for early glucose
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Figure 5. Clinical Phenotyping of Mice with Extreme Alkaline Phosphatase Values
(A) ALPL levels in all individuals in a further in-depth study in male and female mice for individuals from the 11 strains described in the text. The effect observed on
serum ALPL levels shown in Figure 4A was highly reproducible in this independent study, even given a significant difference in the age of the animals in the two
studies (19 weeks versus 46 weeks).
(B) Extracellular PLP levels strongly negatively correlated with ALPL levels in males and females. No correlations were observed between ALPL and extracellular
PL, but the ratio of extracellular PLP/PL was also strongly negatively correlated with ALPL.
(C) Bone volume and surface area were significantly decreased in animals with the B allele of Alpl, consistent with the hypothesis of hypophosphatasia in the
strains with the B allele.
(D) Scheme summarizing the multiple roles of ALPL in metabolism. Before entering tissues, pyridoxal-50-phosphate (PLP) in the plasma must be dephos-
phorylated by ALPL into pyridoxal (PL), which can traverse cell membranes. PL is converted back into PLP by the pyridoxine kinase (PDXK) in the target tissues,
such as liver or brain. PLP is a cofactor in many enzymatic reactions. Circulating ALPL also converts pyrophosphate (PPi) into inorganic phosphate (Pi). Although
PPi inhibits bone mineralization, Pi and calcium (Ca
2+) stimulate it. Low levels of ALPL activity disrupt proper bone development and remodeling via this
mechanism.
Related to Figure S3.response mapped on Chr2 (Figure 6C). Several genes known to
be involved in insulin secretion or type 1 diabetes susceptibility
are located under this peak, including paired box 6 (Pax6),
Cd44, and catalase (Cat) (Chen et al., 2005; Jiang et al., 2011;
Wen et al., 2009). When blood glucose is measured from mice
under fasting conditions, only a single locus is mapped on
Chr7 (Figure 6C). Although there are 91 genes under the locus,
no gene was previously linked to fasting glucose levels in mice
or in humans. Finally, the global AUC is strongly associated
with the QTL located on Chr9 (Figure 6C). This region contains
31 genes, including one that has also been linked with insulin
secretion: plasma membrane-related Ca2+-ATPase-1 (Atp2c1)
(Mitchell et al., 2004).CFunctional analysis of the three QTLs related to glucose
response on Chr1, 2, and 9 uncovered six genes known to be
involved in glucose regulation. However, these QTLs contain
altogether 131 genes, many of which are not yet characterized.
Therefore, we highlighted potential new candidates by finding
the strongest mRNA correlates in liver (Figure 6D). From the list
of the 500 best correlates, we selected candidates from three
categories: (1) genes located under the QTLs on Chr1, 2, and
9; (2) genes that have trans-QTLs mapping to these loci; and
(3) the five top gene correlates with glucose response. The
most significant matches were integrated into the network (Fig-
ure 6D). Protein phosphatase 1 regulatory subunit 3B (Ppp1r3b),
a protein that regulates hepatic glycogen synthesis (Kelsall et al.,ell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc. 1293
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Figure 6. Analysis of Response to an Intraperitoneal Glucose Tolerance Test
(A) Variation of the AUC of the glucose levels from 0 to 120 min.
(B) Network of glucose tolerance response determinants in males and females. Full details are given in Table S2.
(C)Multiple and single QTL heatmap for glucose levels at each time point. Loci switch according to the feeding status of themice. Fasting glucose (t = 0min) maps
appear only on Chr7. The early response to glucose injection (t = 15 min) maps on Chr2 only, whereas the rest of the time points also map on Chr1 and Chr9.
Candidates under each QTL were selected according to existing literature showing their link with type 2 or type 1 diabetes. Further details are given in Figure S4.
(D) Network built around overall glucose response by using gene expression in the liver. Among the top 500 liver mRNA correlates with AUC, two were located on
Chr1 QTL (Arpc5 and BC003331) and one on Chr9 QTL (Rab6b) (yellow boxes). One gene had a transQTL on the Chr1 QTL (Ppp1r3b), four had transQTLs on the
Chr2 QTL (Sfrs6, Clic4, Slco4a1 andMtf2), and one had a transQTL on the Chr9 QTL (Gip) (yellow boxes). Light blue boxes are attributed to the five genes that best
correlated with AUC (Wapal, Rin3, Omt2b, Stradb andMyc). Bold dark blue lines represent1 < r <0.7, light blue lines0.7 < r <0.5, light orange lines 0.5 < r <
0.7 and bold red lines 0.7 < r < 1.
Related to Figure S4 and Table S2.2009), Myc, which plays a role in hepatic glucose uptake and
utilization (Riu et al., 1996), STE20-related kinase adaptor beta
(Stradb), andRab6b, correlated exclusively with AUC (Figure 6D).1294 Cell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc.In contrast, the rest of the candidates were entangled in an
intricate network revolving around the AUC (Mtf2, Slco4a1,
BC030417, Srfs6, Gip, Wapal, Clic4, Arpc5, Rin3, Omt2b, and
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Figure 7. Regulatory Network Underlying Differences in Respiration
(A) Variation amongmale strains of BXDmice in three parameters of respiration: VO2, VCO2, and RER. Variation across and correlation with female strains is given
in Figure S3.
(B) QTL graphs of the three respiratory parameters, VO2 (blue), VCO2 (red), and RER (green). Significance is shown by the red horizontal line, suggestive by the
blue line (LOD > 3.3 and 3.0, respectively). Candidate genes with established links to energy expenditure are listed below the locus (Aox1, Atp5l, Creb3, Ube2r2,
Aqp3, Mrpl54, Pias4, Tab1, and Atf4).
(C) Network graph showing all positional candidates with mRNA expression that correlates significantly with the phenotypes in whole-eye tissue (Geisert et al.,
2009).
(D) Expanded network graph using the same data set, including the top ten mRNA correlates of the phenotypes (light blue boxes). Interestingly, RER had the
strongest top mRNA correlates (Acad9, Dusp10, and Adar), whereas Kif4 was the only significant correlate of all three parameters, and the only strong (jrj > 0.7)
mRNA correlate to VO2 and none were observed for VCO2. Prkca andMgat4a were shared significantly between two parameters. Despite the strong correlation
between VO2 and VCO2, most top correlates were not shared. Bold dark blue lines represent1 < r <0.7, light blue lines0.7 < r <0.5, light orange lines 0.5 <
r < 0.7 and bold red lines 0.7 < r < 1. Bar graphs are expressed as mean + SEM.
Related to Figure S5.BC003331) (Figure 6D). Among these genes, Sfrs6 and Gip have
also been linked with glucose homeostasis (Fossey et al., 2001;
Lyssenko et al., 2011).
Energy Expenditure Networks Link to Underlying mRNA
Expression Differences
The volumes of oxygen consumed (VO2) and CO2 exhaled
(VCO2) give an indirect measurement of mitochondrial function
in vivo—another key complex metabolic phenotype (Auwerx,
2006; Tscho¨p et al., 2012). The respiratory exchange ratio
(RER), defined as VCO2/VO2, is an indirect measurement of the
primary energy substrate used by the organism, e.g., fats, pro-
teins, or carbohydrates. Together, these parameters provide a
window on global energy homeostasis. In contrast to ALPL
and glucose response, the overall variation in these three param-
eters was quitemodest (Figure 7A). Furthermore, these traits hadConly average heritability (Figure 1D). Males and females did not
have significantly different energy expenditure, and the pheno-
types were not significantly correlated by strain (Figures S5A
and S5B). Despite these modest indicators of genetic influence,
these traits mapped significantly and suggestively to five distinct
QTLs (Figure 7B).
Similar to glucose response mapping, common QTLs were
observed, with VO2 and VCO2 containing overlapping peaks on
Chr1, 4, and 11. Somewhat surprisingly, RER maps to separate
QTLs on Chr10 and Chr15 (Figure 7B). All 441 genes under the
five peaks were analyzed for functional relationships to energy
expenditure. Several genes closely related to mitochondrial
function were identified under the QTLs (Figure 7B), for example
ATP synthase H+ transporting mitochondrial F0 complex subunit
G (Atp5l) and mitochondrial ribosomal protein 54 (Mrpl54) (Fig-
ure 7B) (Pagliarini et al., 2008). Several candidates related toell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc. 1295
fat metabolism were also identified, including aldehyde oxidase
1 (Aox1) and activating transcription factor 4 (Atf4, also known as
Creb2) (Seo et al., 2009; Weigert et al., 2008).
All positional candidates were subsequently analyzed for
covariation with VO2, VCO2, and RER in order to identify potential
candidates that were not yet reported in literature. This was done
by using an extensive BXD microarray database of whole-eye
mRNA (Geisert et al., 2009), a tissue containing a variety of cell
types, including neurons and both glycolytic and oxidative
muscle. The network analysis of the 441 genes under the RER,
VO2, and VCO2 QTLs narrowed the list to four genes tightly
covarying with the phenotypes: aquaporin 3 (Aqp3), ubiquitin-
conjugating enzyme E2R 2 (Ube2r2), cAMP responsive element
binding protein 3 (Creb3), and protein inhibitor of activated STAT
4 (Pias4) (Figure 7C). Aqp3 and Pias4 are negative correlates of
RER, whereas Ube2r2 and Creb3 are positive correlates of
VO2 and VCO2 (Figure 7C). As of yet, none of these genes have
been clearly linked to respiration ormitochondrial function. How-
ever, these candidates belong to gene families with clear ties,
suggesting a functional, yet hitherto unknown relationship (fur-
ther connections and references described in Figure S5C).
To expand the small network of positional candidates, the top
500 expression correlates with each trait were calculated and
the top 10 correlates added into the network (Figure 7D). This
network indicated that although VO2 and VCO2 are tightly corre-
lated and share QTLs, several of themost significantly correlated
genes, like profilin 1 (Pfn1), phosphatidylinositol 3-kinase, regu-
latory subunit 1 (Pik3r1), and aryl hydrocarbon receptor repres-
sor (Ahrr), were linked to VCO2 exclusively (Figure 7D). RER
also presented exclusive correlates, such as dual specificity
phosphatase 10 (Dusp10) and acyl-CoA dehydrogenase family,
member 9 (Acad9). Although on first thought it may be surprising
that RER does not network closely with VO2 and VCO2, RER is a
weight-independent measurement of metabolic flexibility. The
common nodes that link VO2 or VCO2 with RER, such as protein
kinase C alpha (Prkca), pantothenate kinase 1 (Pank1), and kine-
sin family member 4 (Kif4) have clear relevance to energy regula-
tion (Leitges et al., 2002). Importantly, the only gene significantly
linked to all energy expenditure phenotypes, Kif4, could affect
metabolism due to its regulation of poly ADP-ribose polymerase
1 (Parp1) (Bai et al., 2011; Midorikawa et al., 2006). Parallel
network analysis using the same analytical technique in liver
showed many similar top candidates, notably including Pank1
and Kif4, which are also linked in the eye network to VO2 or
VCO2 with RER (Figure S5D).
DISCUSSION
One of the main challenges in biomedical research is deter-
mining how genetic factors interact to influence human health-
span and how to develop effective strategies for the diagnosis,
prevention, and treatment of chronic multifactorial metabolic
diseases. Studies in model organisms often focus on single
genes, which allows for precise mechanistic dissection of indi-
vidual pathways yet lacks the same level of real-world genetic
complexity behind variation inmetabolic traits. This can compro-
mise the generality and the translational utility of findings. One of
the first systems for studying complex systems was to use F21296 Cell 150, 1287–1299, September 14, 2012 ª2012 Elsevier Inc.intercrosses, which can be quickly generated. However, unless
an F2 cross is large (n > 500) it will generally have modest
mapping resolution (>20 Mb). Yet the more serious limitation is
that F2 studies cannot be easily replicated or extended because
each organism is genetically unique. To address this problem
and to produce more robust models for systems genetics
approaches, GRPs have been developed such as the BXD
strains, currently the largest available mammalian GRP. The
BXDs constitute a reproducible and high-resolution mapping
panel with5million segregating variants, similar to human pop-
ulations (Altshuler et al., 2010). Perhaps themost important long-
term advantage of RI families is that it is possible to accumulate
huge electronic ‘‘health care’’ records for each of the genotypes
under different conditions and across many scales of biological
organization. Technical error, batch effects, laboratory environ-
mental effects, and other issues can be detected, controlled,
and even exploited simply by expanding the number of strains
or animals used.
When using GRPs, statistical power and mapping precision
are mainly a function of the number of genotypes that are
included in a study. For the metabolic phenotypes measured
here, nongenetic variation within a genotype is generally low
compared to variation across genotypes, demonstrating high
heritability in a standard vivarium environment. Essentially all
measured traits have sufficient heritable variation to motivate
detailed genetic and QTL analyses. Nearly half of the metabolic
phenotypes differed significantly between sexes, thus metabolic
traits do not generalize reliably from one sex to the other. How-
ever, rather than confining analysis to only one sex, balanced
and interleaved sampling of both sexes may offer more benefit.
A total of 140 metabolic traits were analyzed, of which 39 had
significant peak QTLs and an additional 15 had suggestive peak
QTLs. The strongest QTLs are for expression phenotypes and
Mendelian-like classical phenotypes. The most significant QTL,
ALPL expression, was clearly linked to the Alpl gene and caused
by two amino acid changes in evolutionary conserved resi-
dues—R318Q and L324P—which are predicted to change the
3D structure and activity of the ALPL protein. Presence of these
mutations in carriers of the B allele closely mimics downstream
phenotypes of the human disorder hypophosphatasia, primarily
the strong increase in extracellular PLP levels, which along with
ALPL levels provides the most precise biomarker of hypophos-
phatasia (Whyte, 2000). One prominent downstream effect of
ALPL is its effect on promoting bone mineralization by hydro-
lyzing inorganic pyrophosphate (PPi), an inhibitor of hydroxyap-
atite formation, into inorganic phosphate. Consistent with this
hypothesis, mice with the B allele had significantly reduced
bone volume and surface area. These observation have impor-
tant translational value, as Alpl coding variants are known to
contribute to heritable differences in bonemetabolism in humans
(Nielson et al., 2011).
Most metabolic traits are, however, complex and map to
multiple loci. For example, glucose response levels are associ-
ated with three loci and collectively contain six established posi-
tional candidates. Three of these candidates—Cd44, Cat, and
Pax6—are located in the Chr2 locus and linked to insulin secre-
tion or type I diabetes. In line with this linkage, a large F2 cross
study of basal insulin levels also revealed a QTL on the same
region (Mehrabian et al., 1998). Studies in humans have identi-
fied only a single insulin sensitivity gene (PPARg [Deeb et al.,
1998]), yet GWAS have identified several genes that control
insulin secretion (McCarthy, 2010). In addition to those identified
genes that are clear candidates for glucose response, it is
possible, even likely, that other genes under these loci also influ-
ence glucose/insulin response.
Genetic mapping of the energy expenditure traits yields five
distinct QTLs containing over 400 positional candidate genes,
including established genes in oxidative metabolism in two
general categories: those tied to general mitochondrial function
(e.g., Mrpl54 and Atp5l) and those tied to the regulation of lipid
metabolism (e.g., Aox1 and Atf4). Atp5l is a component of the
complex V ATP synthesis machinery in oxidative phosphoryla-
tion, whereas Mrpl54 is part of the mitochondrial ribosome
responsible for the translation of the 13 proteins encoded by
the mitochondrial genome that are key components of the elec-
tron transport chain (Pagliarini et al., 2008). From the other angle,
Aox1 is involved in lipid metabolism and produces reactive
oxygen species as byproducts (Weigert et al., 2008) that are
known to affect respiration (Balaban et al., 2005). Atf4 (aka
Creb2) is an established regulator of lipid and energy homeo-
stasis (Seo et al., 2009).
By combining QTLmapping with network building, it becomes
practical to expand the phenotype and positional candidate
networks to highlight intriguing candidates genes that are good
targets for mechanistic studies of glycaemia and energy expen-
diture. For example, the serine/arginine-rich splicing factor 6
(Sfrs6) is among the top correlates of glucose response, and it
is associated with type 2 diabetes susceptibility in humans (Fos-
sey et al., 2001). Many other relevant genes appear as top
correlates when networks are extended further. The glucose-
dependent insulinotropic polypeptide (Gip) is only vicariously
connected to the phenotypes, but it has a strong functional rela-
tion: it promotes pancreatic islet function and exerts pro-survival
actions in humans (Lyssenko et al., 2011).
As with glucose response, network identification of the top
mRNA correlates with the phenotype revealed a me´lange of
genes involved in different aspects of energy regulation. For
example, the only significant correlate of all three parameters,
Kif4, regulates PARP1, the major NAD+ consuming enzyme in
the cell (Houtkooper et al., 2010). PARP1 critically controls oxi-
dative metabolism due to its competition with SIRT1 for a com-
mon and limiting NAD+ pool in the cell (Bai et al., 2011). Acad9,
linked with RER, is essential for complex I assembly via its
impact on Ndufa1 and Ecsit (Haack et al., 2010; Nouws et al.,
2010). However, other genes without known ties to lipid or glu-
cose metabolism also appeared as top correlates, for example
Ahrr and Pfn1.
In terms of building and testing models of complex processes
such as metabolism, even traits with low heritability or without
strong QTLs provide great value. For instance, although VCO2
is not linked to unique QTLs, its inclusion in network analysis
not only strengthens the common interacting genes with VO2,
but also uncovers unique genes, which may be novel to the
phenotype. Likewise, the integration of gene expression from
liver to the glucose tolerance network increases the power to
identify genes that are specific to one organ function—in thisCcase hepatic glucose metabolism. For both analyses, it is likely
that more novel genes involved in glucose response and energy
expenditure remain under the loci described. Such network
construction underscores the usefulness of the BXD GRP as
a powerful resource for hypothesis generation and validation
in a field as complex as metabolism. Further complementary
phenotypic measurements of the BXDs under challenged condi-
tions may help refine these regulatory pathways.
Most analyses in this resource—including all of Figures 6 and
7—can be generated entirely with public access to www.
genenetwork.org. The phenotypes from this study can be found
under BXD phenotypes by searching for ‘‘LISP1’’ and either
analyzed on-site or downloaded for separate analysis. A wide
variety of public microarray data and phenotype data from other
studies on the same BXD strains are also available for trans-
lational analyses on GeneNetwork. Together this makes the
BXDs among the largest and best-categorized family of isogenic
strains, and we expect resources like this to serve as the back-
bone for murine studies on complex disease for the coming
decade.
EXPERIMENTAL PROCEDURES
Animals
We acquired 25 BXD strains of females and 42 BXD strains of males from the
University of Tennessee Health Science Center (Memphis, TN, USA). Strains
and sexes were housed together with two to four animals per cage under
12 hr light, 12 hr dark cycle with ad libitum access to water and chow diet
food (D04, SAFE, Augy, France) at all times. The studies shown in Figure 5
were carried out in a subset of these strains at a significantly older age
(40–52 weeks) than the animals in the primary study protocol (8–20 weeks).
General Study Plan and Phenotyping tests
The general outline of the phenotyping study is described in the results section
and summarized in Figure 1C. All tests were carried out according to rigorous
standard operating procedures (SOP) established and validated within the
EUMODIC EMPReSS program (Champy et al., 2004; Champy et al., 2008).
Bioinformatics and Statistical Analysis
R was used for the analysis of phenotypic data, and GeneNetwork (www.
genenetwork.org) was used for all genetic analyses (Chesler et al., 2004).
Student’s t test was used to calculate significance between males and
females. Pearson’s r and p values were calculated to determine magnitude
and significance of correlations except when otherwise indicated. Correlation
networks and QTL calculations are Bonferroni-corrected for multiple testing.
The y axes of bar graphs are often cropped to highlight strain differences.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.08.012.
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